Literature DB >> 33634340

Contributions of HOTAIR polymorphisms to the susceptibility of cancer.

Hu-Nian Li1, Na Deng2, Xu Zhao1, Jie Liu1, Ting He3, Xi-Wei Ding4.   

Abstract

OBJECTIVE: Hox transcript antisense intergenic RNA (HOTAIR), a lncRNA, functions as a critical regulator in cancer development. A plenty of case-control studies were conducted to assess the actual relationship of HOTAIR gene generic variants on cancer susceptibility, yet conflicting conclusions remain. Herein, we carried out this up-to-date meta-analysis to get a better understanding of such relationship by incorporating all eligible case-control studies.
MATERIALS AND METHODS: Six widely investigated polymorphisms were included in this meta-analysis: rs920778, rs4759314, rs7958904, rs874945, rs1899663, and rs12826786. We retrieved relevant studies from databases PubMed, EMBASE, Medline, CNKI and Wanfang update to June 2020. We applied odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the relationship strengths.
RESULTS: Our findings indicate that rs920778, rs4759314, rs874945, rs12826786 polymorphism significantly increased with susceptibility to overall cancer. However, rs7958904, rs1899663 under any five genetic models could not impact susceptibility to overall cancer. Furthermore, altered cancer risk was detected when the data were stratified by cancer type, ethnicity, the source of controls, and HWE in all the SNPs.
CONCLUSIONS: These findings of the meta-analysis suggest that HOTAIR polymorphisms may predispose to cancer susceptibility.

Entities:  

Keywords:  Cancer; HOTAIR; Meta-analysis; Polymorphism; Risk

Year:  2021        PMID: 33634340     DOI: 10.1007/s10147-021-01884-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  58 in total

1.  MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.

Authors:  Yanqiang Wang; Huiling He; Wei Li; John Phay; Rulong Shen; Lianbo Yu; Baris Hancioglu; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

Review 2.  Nature, Nurture, and Cancer Risks: Genetic and Nutritional Contributions to Cancer.

Authors:  Evropi Theodoratou; Maria Timofeeva; Xue Li; Xiangrui Meng; John P A Ioannidis
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

Review 3.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

Review 4.  Long Noncoding RNAs in Cancer and Therapeutic Potential.

Authors:  Arun Renganathan; Emanuela Felley-Bosco
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.

Authors:  Gaurav Kumar Pandey; Sanhita Mitra; Santhilal Subhash; Falk Hertwig; Meena Kanduri; Kankadeb Mishra; Susanne Fransson; Abiarchana Ganeshram; Tanmoy Mondal; Sashidhar Bandaru; Malin Ostensson; Levent M Akyürek; Jonas Abrahamsson; Susan Pfeifer; Erik Larsson; Leming Shi; Zhiyu Peng; Matthias Fischer; Tommy Martinsson; Fredrik Hedborg; Per Kogner; Chandrasekhar Kanduri
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 6.  Molecular and genetic epidemiology of cancer in low- and medium-income countries.

Authors:  Jyoti Malhotra
Journal:  Ann Glob Health       Date:  2014 Sep-Oct       Impact factor: 2.462

7.  Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.

Authors:  Haiyang Guo; Musaddeque Ahmed; Fan Zhang; Cindy Q Yao; SiDe Li; Yi Liang; Junjie Hua; Fraser Soares; Yifei Sun; Jens Langstein; Yuchen Li; Christine Poon; Swneke D Bailey; Kinjal Desai; Teng Fei; Qiyuan Li; Dorota H Sendorek; Michael Fraser; John R Prensner; Trevor J Pugh; Mark Pomerantz; Robert G Bristow; Mathieu Lupien; Felix Y Feng; Paul C Boutros; Matthew L Freedman; Martin J Walsh; Housheng Hansen He
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

Review 8.  SNPs in cancer research and treatment.

Authors:  H C Erichsen; S J Chanock
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

9.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.

Authors:  Hui Ling; Riccardo Spizzo; Yaser Atlasi; Milena Nicoloso; Masayoshi Shimizu; Roxana S Redis; Naohiro Nishida; Roberta Gafà; Jian Song; Zhiyi Guo; Cristina Ivan; Elisa Barbarotto; Ingrid De Vries; Xinna Zhang; Manuela Ferracin; Mike Churchman; Janneke F van Galen; Berna H Beverloo; Maryam Shariati; Franziska Haderk; Marcos R Estecio; Guillermo Garcia-Manero; Gijs A Patijn; David C Gotley; Vikas Bhardwaj; Imad Shureiqi; Subrata Sen; Asha S Multani; James Welsh; Ken Yamamoto; Itsuki Taniguchi; Min-Ae Song; Steven Gallinger; Graham Casey; Stephen N Thibodeau; Loïc Le Marchand; Maarit Tiirikainen; Sendurai A Mani; Wei Zhang; Ramana V Davuluri; Koshi Mimori; Masaki Mori; Anieta M Sieuwerts; John W M Martens; Ian Tomlinson; Massimo Negrini; Ioana Berindan-Neagoe; John A Foekens; Stanley R Hamilton; Giovanni Lanza; Scott Kopetz; Riccardo Fodde; George A Calin
Journal:  Genome Res       Date:  2013-06-24       Impact factor: 9.043

10.  Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.

Authors:  Zhen-Jian Zhuo; Wei Liu; Jiao Zhang; Jinhong Zhu; Ruizhong Zhang; Jue Tang; Tianyou Yang; Yan Zou; Jing He; Huimin Xia
Journal:  EBioMedicine       Date:  2018-03-07       Impact factor: 8.143

View more
  2 in total

1.  Association of HOTAIR rs1899663 G>T Polymorphism with Colorectal Cancer in the Turkish Population: A Case-Control Study.

Authors:  Berrin Yalınbaş Kaya; Betül Peker; Fuzuli Tuğrul; Özge Alkan Tali; Süleyman Bayram
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

2.  The Association of MEG3 Gene rs7158663 Polymorphism With Cancer Susceptibility.

Authors:  Xueren Gao; Xianyang Li; Shulong Zhang; Xiaoting Wang
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.